A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis-Reference-Cited by-同舟云学术

A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis

Published:2023-07 Issue:4 Volume:49 Page:101455
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Potter Kathryn J.,Racine Florence,Bonhoure Anne,Boudreau Valérie,Bélanger Noémie,Coriati Adèle,Shohoudi Azadeh,Lavoie Annick,Senior Peter A.,Mailhot Geneviève,Rabasa-Lhoret Rémi^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. ISPAD clinical practice consensus guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents;Moran;Pediatr Diabetes,2018

2. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society;Moran;Diabetes Care,2010

3. Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps;Prentice;Paediatr Respir Rev,2022

4. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus;Noronha;Pediatr Diabetes,2014

5. How patients' representations of cystic fibrosis-related diabetes inform their health behaviours;Sylvain;Psychol Health,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis year in review 2023;Pediatric Pulmonology;2024-07-26

2. Current Perspectives and Innovative Approaches in Treating Cystic Fibrosis-Related Diabetes: Unveiling Mechanisms for Precision Medicine;Current Drug Therapy;2024-05-24

3. Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes;Diabetes Research and Clinical Practice;2024-02

4. Advances in cystic fibrosis-related diabetes: Current status and future directions;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-11